Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced results from a long-term (104 weeks) Phase 3 clinical study which showed that the investigational compound dapagliflozin added to metformin sustained reductions of blood
Kaohsiung Mayor Chen Chu will take a break of one to two weeks for treatment at hospital after suffering a minor fracture in the lumbar vertebrae in an accidental fall during a visit to Yilan County in northeastern Taiwan, city government officials said y
Kaohsiung Mayor Chen Chu will take a break of one to two weeks for treatment at hospital after suffering a minor fracture in the lumbar vertebrae. -The China Post/ANN